-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
December 01, 2015 - confidence in findings from the comparisons of
remaining treatment options was low or insufficient,
indicating … review can be helpful to physicians because they
can provide a summary of the available evidence base
indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
November 03, 2014 - Topic 0613 Tympanostomy Tubes NSD FINAL
Tympanostomy Tubes in Children
Nomination Summary Document
Results of Topic Selection Process & Next Steps
§ Th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
November 28, 2023 - Evaluation of Dietary Protein Intake Requirements
Evidence-Based Practice Center Systematic Review Protocol
Project Title: Evaluation of Dietary Protein Intake Requirements
Publication Date: June 2, 2023
Amendment Date(s): November 17, 2023, November 28, 2023
(Amendments Details–see Section VI)
I. B…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
September 06, 2023 - EHC Protocol: Updating the Measurement Criteria for AHRQ's National Healthcare Quality and Disparities Report
Evidence-based Practice Center Technical Brief Protocol
Project Title: Updating the Measurement Criteria for AHRQ’s National
Healthcare Quality and Disparities Report (NHQDR)
I. Background and Objectives…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - Appendix E-1
Appendix E-1. Data Abstraction of Study Characteristics
Table E-1-1
Table E-1-1. Study characteristics of RCTs addressing Key Questions 1 and 2
Key Question Author, Year
Country
Quality Rating Demographics and Baseline Characteristics Other Population Characteristics Reason fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update
Comparative Effectiveness Review
Number 244
Safety of Vaccines Used for Routine
Immunization in the United States: An Update
Evidence Summary
Main Points
Background and Purpose
Considere…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - 1
Comparative Effectiveness Review
Number 48
Hematopoietic Stem-Cell Transplantation in the
Pediatric Population
Executive Summary
Background
Hematopoietic stem-cell transplantation
(HSCT) refers to a procedure in which
hematopoietic progenitor cells, including
repopulating stem cells, are infused
to restore …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 1, 2010
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
September 06, 2023 - Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR)
Evidence-based Practice Center Technical Brief Protocol
Project Title: Updating the Framework for AHRQ’s National Healthcare
Quality and Disparities Report (NHQDR)
I. Background and Objectives for the Technical…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy
Comparative Effectiveness Review
Number 234
Management of Primary Headaches
in Pregnancy
Evidence Summary
Main Points
• Prevention of primary headache in women who are pregnant (or attempting to
become pre…
-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-6-protocol.pdf
December 07, 2024 - information
provided by study authors in evidence table notes or other sections of the final report indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
June 12, 2012 - The overall strength of evidence will be graded as “high” (indicating high confidence that the
evidence … further research is very unlikely to change our confidence in
the estimate of effect), “moderate” (indicating … research may change our confidence in the estimate of effect and
may change the estimate), “low” (indicating … our confidence in the estimate of effect and is
likely to change the estimate), or “insufficient” (indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - We classified
evidence into four basic categories: (1) “high” grade,
indicating high confidence that … is very unlikely
to change our confidence in the estimate of the effect;
(2) “moderate” grade, indicating … change our confidence in the estimate of the effect
and may change the estimate; (3) “low” grade, indicating … in the estimate of the effect and is likely to change
the estimate; and (4) “insufficient” grade, indicating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
September 07, 2012 - I think the data indicating
differential efficacy with different risks for preterm birth is
sufficient
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - the basis of
platelet reactivity units found a summary RR of 1.21 (95%
CI, 0.83 to 1.77; p=0.313), indicating … Of these,
11 did not report statistically significant results and
produced relatively wide CIs, indicating … A meta-analysis of the four
studies found a summary RR of 3.37 (95% CI, 1.59 to 7.1;
p=0.015), indicating … Points were often close to the chance diagonal, indicating
that test performance was generally poor. … Consequently, data
were sparse and CIs around effect estimates were wide,
indicating substantial uncertainty
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - diagnosis of PCD (MM,
NSMM, or AL amyloidosis), is the SFLC assay better than
traditional tests in indicating … diagnosis of
PCD (MM, NSMM, or AL amyloidosis), is the SFLC
assay better than traditional tests in indicating … patients with normalization of
the SFLC ratio still had 5 percent or more of plasma cells
in marrow, indicating